Cencora (COR)
NYSEHealth CareMedical DistributionSnapshot 2026-07-07
$304.49+1.99%
Close 2026-07-07 · 1-day change
Reading COR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track COR free→NYSEHealth CareMedical DistributionSnapshot 2026-07-07
Reading COR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track COR free→QuarterlyIQ Insights · COR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 328,680.0 | 321,332.8 | 293,958.6 | 262,173.4 | 238,587.0 | 213,988.8 | 189,893.9 | 179,589.1 | 146,849.7 | 146,849.7 | 146,849.7 | 135,961.8 | 78,080.8 | 78,080.8 | 78,080.8 | 80,217.6 | 70,189.7 | 70,189.7 |
| Total Revenues | 328,680.0 | 321,332.8 | 293,958.6 | 262,173.4 | 238,587.0 | 213,988.8 | 189,893.9 | 179,589.1 | 146,849.7 | 146,849.7 | 146,849.7 | 135,961.8 | 78,080.8 | 78,080.8 | 78,080.8 | 80,217.6 | 70,189.7 | 70,189.7 |
| Cost of Revenues | 316,158.9 | 309,854.3 | 284,048.6 | 253,213.9 | 230,290.6 | 207,045.6 | 184,702.0 | 174,450.8 | 142,577.1 | — | — | — | — | — | — | — | — | — |
| Gross Profit | 12,521.1 | 11,478.5 | 9,910.0 | 8,959.5 | 8,296.4 | 6,943.2 | 5,191.9 | 5,138.3 | 4,272.6 | 4,272.6 | 4,272.6 | 3,529.3 | 2,634.7 | 2,634.7 | 2,634.7 | 2,539.1 | 2,047.0 | 2,047.0 |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 7,194.6 | 6,493.8 | 5,661.1 | 5,310.0 | 4,849.0 | 3,594.3 | 2,767.2 | 2,663.5 | 2,091.2 | 2,091.2 | 2,091.2 | 1,918.0 | 1,152.6 | 1,152.6 | 1,152.6 | 1,198.0 | 1,119.4 | 1,119.4 |
| Operating Income | 2,789.2 | 2,628.6 | 2,175.2 | 2,340.7 | 2,366.4 | 2,354.2 | (5,135.4) | 1,111.9 | 1,525.8 | 1,525.8 | 1,525.8 | 417.4 | 1,303.6 | 1,303.6 | 1,303.6 | 1,202.7 | 827.9 | 827.9 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Other Non-Operating Income / Expenses | 1,089.7 | (78.7) | (14.3) | 49.0 | 27.4 | 41.7 | 1.6 | 13.0 | 5.0 | 5.0 | 5.0 | (13.6) | 5.8 | 5.8 | 5.8 | 4.6 | (2.0) | (2.0) |
| Asset Writedown | — | 837.4 | 418.0 | 0.0 | 80.9 | 31.7 | 361.7 | 570.0 | 0.0 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 3,506.4 | 2,258.3 | 2,004.0 | 2,160.8 | 2,183.1 | 2,221.9 | (5,293.8) | 967.1 | 1,390.9 | 1,390.9 | 1,390.9 | 274.1 | 1,216.9 | 1,216.9 | 1,216.9 | 1,130.6 | 761.3 | 761.3 |
| Income Tax Expense | 954.1 | 690.5 | 484.7 | 428.3 | 516.5 | 677.3 | (1,894.3) | 113.0 | (37.0) | (37.0) | (37.0) | 409.0 | 455.5 | 455.5 | 455.5 | 424.0 | 292.3 | 292.3 |
| Net Income | ||||||||||||||||||
| Minority Interest | 3.7 | 13.6 | 10.2 | (12.7) | (32.3) | 4.7 | 9.2 | (1.2) | 0.0 | — | — | — | — | — | — | — | — | — |
| Net Income | 2,548.7 | 1,554.2 | 1,509.1 | 1,745.3 | 1,698.8 | 1,539.9 | (3,408.7) | 855.4 | 1,427.9 | 1,427.9 | 1,427.9 | (134.9) | 719.0 | 719.0 | 719.0 | 706.6 | 250.6 | 250.6 |
| Per Share | ||||||||||||||||||
| Basic EPS | 13.10 | 8.02 | 7.60 | 8.62 | 8.15 | 7.48 | (16.65) | 4.07 | 6.73 | 6.73 | 6.73 | (0.62) | 2.84 | 2.84 | 2.84 | 2.59 | 0.78 | 0.78 |
| Diluted EPS | 13.04 | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 | (16.65) | 4.04 | 6.32 | 6.32 | 6.32 | (0.62) | 2.80 | 2.80 | 2.80 | 2.54 | 0.77 | 0.77 |
| Revenue per Share | 1,682.23 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 2.20 | 2.04 | 1.94 | 1.84 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 194.5 | 193.8 | 198.5 | 202.5 | 208.5 | 205.9 | 204.8 | 210.2 | 212.2 | 212.2 | 212.2 | 0.2 | 252.9 | 252.9 | 252.9 | 272.5 | 321.3 | 321.3 |
| Diluted Weighted Avg Shares | 195.4 | 195.2 | 200.3 | 204.6 | 211.2 | 208.5 | 204.8 | 211.8 | 226.0 | 226.0 | 226.0 | 0.2 | 256.9 | 256.9 | 256.9 | 277.7 | 324.9 | 324.9 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | 3,679.7 | 3,267.2 | 3,304.6 | 3,060.3 | 2,859.4 | (4,744.3) | 1,574.3 | 1,890.5 | 1,890.5 | 1,890.5 | 660.7 | 1,438.0 | 1,438.0 | 1,438.0 | — | — | — |
| EBIT | 2,789.2 | 2,628.6 | 2,175.2 | 2,340.7 | 2,366.4 | 2,354.2 | (5,135.4) | 1,111.9 | 1,525.8 | 1,525.8 | 1,525.8 | 417.4 | 1,303.6 | 1,303.6 | 1,303.6 | 1,202.7 | 827.9 | 827.9 |
| Effective Tax Rate | 27.2% | 30.6% | 24.2% | 19.8% | 23.7% | 30.5% | 35.8% | 11.7% | -2.7% | -2.7% | -2.7% | 149.2% | 37.4% | 37.4% | 37.4% | 37.5% | 38.4% | 38.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.